Effects of Transcranial Direct Current Stimulation (tDCS) and Motor Learning in Children With Cerebral Palsy (CP)
|ClinicalTrials.gov Identifier: NCT01852474|
Recruitment Status : Completed
First Posted : May 13, 2013
Last Update Posted : March 21, 2017
|Condition or disease||Intervention/treatment||Phase|
|Cerebral Palsy||Device: Transcranial Direct Current Stimulation (tDCS)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||5 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effects of tDCS in Cortical Plasticity and Motor Learning in Children With Cerebral Palsy|
|Actual Study Start Date :||May 2013|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||May 2016|
Experimental: Active tDCS
Subjects will receive active tDCS stimulation for 5 sessions (20m/each) over one week.
Device: Transcranial Direct Current Stimulation (tDCS)
Subjects will receive tDCS stimulation 1x per day for 5 days (over the period of 1 week). Each session will be 20 minutes long. The subject will receive active stimulation for the entire 20 minutes.
- Changes in motor assessments [ Time Frame: Approximately 2 weeks ]Investigators will measure changes in kinematic (sensor) assessments from baseline to follow-up. The sensor will collect Inertial Measurements Units (IMU) and complex motion sensing, as measured by accelerometer/gyroscope/magnetometer of freedom motion capture.
- Changes in TMS measurements [ Time Frame: Approximately 2 weeks ]Investigators will measure change in TMS measurements from baseline to follow-up. TMS measures will consist of: motor threshold, motor evoked potentials (MEP's), transcallosal inhibition, and examinations of intracortical inhibition and facilitation.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01852474
|United States, Massachusetts|
|Spaulding Rehabilitation Network Research Institute|
|Charlestown, Massachusetts, United States, 02129|
|Principal Investigator:||Felipe Fregni, MD PhD MPH||Spaulding Rehabilitation Hospital|